Global Allergy Immunotherapies Market 2020-2024, Featuring Key Vendor Profiles Including Aimmune Therapeutics, DBV Technologies and Merck KGaA - ResearchAndMarkets.com

DUBLIN--()--The "Global Allergy Immunotherapies Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.

This report on the global allergy immunotherapies market provides analysis on market size and forecasts trends, growth drivers, and challenges. The report includes a vendor analyis on key market players.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of allergies. In addition, the growing popularity of slit is anticipated to boost the growth of the global allergy immunotherapies market.

The global allergy immunotherapies market is segmented as below:

Product:

  • SCIT
  • SLIT

Geographic Segmentation:

  • APAC
  • Europe
  • MEA
  • North America
  • South America

Prominent vendors in global allergy immunotherapies market

The report provides a detailed analysis of key vendors operating in the global allergy immunotherapies market 2020-2024, including Aimmune Therapeutics Inc., ALK-Abell AS, Allergy Therapeutics Plc, ASIT Biotech SA, DBV Technologies SA, HAL Allergy BV, Jubilant Life Sciences Ltd., Laboratorios LETI SLU, Merck KGaA and Stallergenes Greer Plc .

Key Topics Covered:

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product placement
  • SCIT - Market size and forecast 2019-2024
  • SLIT - Market size and forecast 2019-2024
  • Market opportunity by Product

Customer landscape

  • Overview

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • Europe - Market size and forecast 2019-2024
  • North America - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • MEA - Market size and forecast 2019-2024
  • South America - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography

Drivers, Challenges, and Trends

  • Market drivers
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Volume driver - Demand shift in adjacent markets
  • Price driver - Inflation
  • Price driver - Shift from lower to higher-priced units
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Aimmune Therapeutics Inc.
  • ALK-Abell AS
  • Allergy Therapeutics Plc
  • ASIT Biotech SA
  • DBV Technologies SA
  • HAL Allergy BV
  • Jubilant Life Sciences Ltd.
  • Laboratorios LETI SLU
  • Merck KGaA
  • Stallergenes Greer Plc

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

     

For more information about this report visit https://www.researchandmarkets.com/r/ucr6qb

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900